Quotient Therapeutics
Pioneering somatic genomics
Cambridge, United States · Founded 2022 · $50.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- quotient-tx.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series CNov 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Flagship Pioneering company pioneering somatic genomics to develop transformative medicines from a new frontier of genetics.
Summary
Quotient Therapeutics is a Biotech company based in Cambridge, United States, founded in 2022. It has raised $50.0M in total across 1 round, most recently a $50.0M Series C round in Nov 2023. Investors include Flagship Pioneering.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/quotient-therapeutics"><img src="https://indexed.vc/api/badge/company/quotient-therapeutics" alt="Quotient Therapeutics on Indexed.vc" width="260" height="76" /></a>